Intelligence Β· Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
hypo-fractionated SRS
United Therapeutics Europe Ltd
Metastatic Cancer
1 trial -
iC9.GD2.CAR.IL-15 T Infusion
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
iC9.GD2.CAR.IL-15 T-cells
United Therapeutics Europe Ltd
Neuroblastoma
1 trial -
iNexinβ’ (0.08% aCT1)
United Therapeutics Europe Ltd
Dry Eye Disease
1 trial -
iTBS to the left dlPFC
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
idronoxil
KAZIA THERAPEUTICS LTD
Unspecified Adult Solid Tumor, Protocol Specific
1 trial -
illuccix 68Ga-PSMA-11 Total Body PET-CT
Telix Innovations
Metastatic Castration-resistant Prostate Cancer
1 trial -
iloperidone (oral tablet)
Vanda Pharmaceuticals Netherlands B.V.
Safety and Tolerability of Iloperidone
1 trial -
imatinib mesylate
Children's Hospital of Fudan University
Leukemia
1 trial -
immediate release guanfacine hydrochloride
Takeda
Healthy Volunteers
1 trial -
indibulin
Alaunos Therapeutics
Solid Tumors
2 trials -
indibulin
Alaunos Therapeutics
Advanced Cancer
1 trial -
interceptive orthodontic treatments
NORTHWEST BIOTHERAPEUTICS INC
Malocclusion
1 trial -
interleukin-4 PE38KDEL cytotoxin
NEUROCRINE BIOSCIENCES INC
Breast Cancer
1 trial -
intraconazole
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
1 trial -
iridoid enriched mixed fruit beverage
International Peace Maternity and Child Health Hospital
Oxidative Stress
1 trial -
itraconazole
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
ivosidenib (AG-120)
Agios Netherlands B.V.
Healthy
1 trial -
ketamine
Summit Therapeutics
Multiple Sclerosis
1 trial -
l-THP (l-tetrahydropalmatine)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use
1 trial -
laquinimod
Teva Pharma GmbH
Pharmacokinetics
1 trial -
limonene containing massage oil
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
linvoseltamab
Regeneron UK Limited
Food Allergy
1 trial -
lipegfilgrastim
Teva Pharma GmbH
Pharmacokinetics
1 trial -
liposomal cytarabine
Pacira Ireland Limited
Brain and Central Nervous System Tumors
1 trial -
locally manufactured adoptive cellular therapy (ACT) product
Iovance Biotherapeutics B.V.
Malignant Pleural Effusion
1 trial -
lofexidine HCl
BRIGHT MINDS BIOSCIENCES INC.
Renally Impaired Subjects
1 trial -
lumacaftor 200 mg q12h + ivacaftor 250 mg q12h
Vertex Pharmaceuticals (Australia) Pty.
Hepatic Impairment
1 trial -
lumbar puncture
Takeda
Crohn's Disease
1 trial -
mHealth application (custom)
BRIGHT MINDS BIOSCIENCES INC.
Cognitive Function Abnormal
1 trial -
mPEG-r-crisantaspase
Jazz Pharmaceuticals Ireland Limited
Hematologic Malignancies
1 trial -
medroxyprogesterone acetate
Teva Pharma GmbH
Healthy
1 trial -
mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral Vascular Disease
1 trial -
metformin hydrochloride 500 mg tablet
PMV Pharmaceuticals
TP53 Y220C Mutation
1 trial -
metyrapone & oxazepam
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorder
1 trial -
mifepristone + fluvastatin
CORCEPT THERAPEUTICS INC
Healthy Subjects
1 trial -
milatuzumab
United Therapeutics Europe Ltd
Lupus Erythematosus, Cutaneous
1 trial -
mipomersen
IONIS PHARMACEUTICALS INC
Healthy Volunteer
3 trials -
mipomersen sodium
IONIS PHARMACEUTICALS INC
Healthy
1 trial -
mitoxantrone hydrochloride
Karyopharm Therapeutics Inc
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
1 trial -
mitragynine
BRIGHT MINDS BIOSCIENCES INC.
Safety and Tolerability in Healthy Subjects
1 trial -
monoclonal antibody M-T412
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
namilumab (MT203)
Takeda
Rheumatoid Arthritis
1 trial -
narfurine hydrochloride orally disintegrating tablets
The First People's Hospital of Lianyungang
Improvement of Pruritus in Hemodialysis Patients
1 trial -
neratinib
PUMA BIOTECHNOLOGY, INC.
Healthy
5 trials -
neratinib
PUMA BIOTECHNOLOGY, INC.
Tumors
1 trial -
nesvacumab (REGN910/ SAR307746)
Regeneron UK Limited
Solid Tumors
2 trials -
new formulations of 611
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Atopic Dermatitis
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources Β· All pipeline programs